JP2004536785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536785A5 JP2004536785A5 JP2002567348A JP2002567348A JP2004536785A5 JP 2004536785 A5 JP2004536785 A5 JP 2004536785A5 JP 2002567348 A JP2002567348 A JP 2002567348A JP 2002567348 A JP2002567348 A JP 2002567348A JP 2004536785 A5 JP2004536785 A5 JP 2004536785A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- vaccine
- influenza
- virus
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000463 material Substances 0.000 claims 6
- 229960005486 vaccine Drugs 0.000 claims 6
- 241000700605 Viruses Species 0.000 claims 5
- 206010022000 influenza Diseases 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 238000001914 filtration Methods 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 229960003971 influenza vaccine Drugs 0.000 claims 3
- 230000003612 virological effect Effects 0.000 claims 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 238000005119 centrifugation Methods 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 238000005352 clarification Methods 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 101710154606 Hemagglutinin Proteins 0.000 claims 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 1
- 101710176177 Protein A56 Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 210000000991 chicken egg Anatomy 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 238000000432 density-gradient centrifugation Methods 0.000 claims 1
- 229960003964 deoxycholic acid Drugs 0.000 claims 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical group C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000000185 hemagglutinin Substances 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002736 nonionic surfactant Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000000644 propagated effect Effects 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Chemical class 0.000 claims 1
- 229930182490 saponin Chemical class 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 claims 1
- 238000011146 sterile filtration Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 238000000108 ultra-filtration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0104542A GB0104542D0 (en) | 2001-02-23 | 2001-02-23 | Novel vaccine |
| GB0108366A GB0108366D0 (en) | 2001-04-03 | 2001-04-03 | Novel compounds |
| PCT/EP2002/001843 WO2002067983A1 (en) | 2001-02-23 | 2002-02-21 | Novel vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004536785A JP2004536785A (ja) | 2004-12-09 |
| JP2004536785A5 true JP2004536785A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
Family
ID=26245752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567348A Withdrawn JP2004536785A (ja) | 2001-02-23 | 2002-02-21 | 新規なワクチン |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20040096463A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1361889A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004536785A (cg-RX-API-DMAC7.html) |
| AR (1) | AR032575A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2438960A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002067983A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL355287A1 (en) * | 1999-09-24 | 2004-04-05 | Smithkline Beecham Biologicals S.A. | Intranasal influenza virus vaccine |
| EP1361890B1 (en) * | 2001-02-23 | 2011-03-30 | GlaxoSmithKline Biologicals s.a. | Influenza vaccine formulations for intradermal delivery |
| CA2445120A1 (en) * | 2001-04-27 | 2002-11-07 | Glaxosmithkline Biologicals Sa | Devices for the intradermal administration of influenza vaccines |
| MY134424A (en) * | 2001-05-30 | 2007-12-31 | Saechsisches Serumwerk | Stable influenza virus preparations with low or no amount of thiomersal |
| CN1253220C (zh) * | 2001-06-29 | 2006-04-26 | 贝克顿迪肯森公司 | 通过微管在真皮内输入疫苗和基因治疗剂 |
| US7588774B2 (en) | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
| AU2004249802B2 (en) | 2003-06-20 | 2007-06-28 | Microbix Biosystems Inc. | Improvements in virus production |
| US20080254065A1 (en) | 2004-03-09 | 2008-10-16 | Chiron Corporation | Influenza Virus Vaccines |
| CN101124343A (zh) | 2004-04-01 | 2008-02-13 | 阿尔扎公司 | 用于经皮肤输送流感疫苗的装置和方法 |
| WO2005113756A1 (en) * | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
| AU2005314563B2 (en) * | 2004-11-03 | 2011-06-30 | Seqirus UK Limited | Influenza vaccination |
| WO2006060710A2 (en) * | 2004-12-02 | 2006-06-08 | Becton, Dickinson And Company | Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents |
| ATE494906T1 (de) | 2005-11-01 | 2011-01-15 | Novartis Vaccines & Diagnostic | Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna |
| WO2007052055A1 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| US11707520B2 (en) | 2005-11-03 | 2023-07-25 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| ES2377884T3 (es) | 2005-11-04 | 2012-04-02 | Novartis Vaccines And Diagnostics S.R.L. | Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores |
| NZ594482A (en) | 2005-11-04 | 2012-11-30 | Novartis Vaccines & Diagnostic | Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant |
| CA2628424A1 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics S.R.L. | Adjuvanted influenza vaccines including cytokine-inducing agents |
| KR20080069232A (ko) | 2005-11-04 | 2008-07-25 | 노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. | 스플리트 인플루엔자 백신에 대한 보조제로서 유리 수성상계면활성제를 갖는 에멀젼 |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| PL2478916T3 (pl) | 2006-01-27 | 2020-11-16 | Seqirus UK Limited | Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy |
| WO2007110776A1 (en) | 2006-03-24 | 2007-10-04 | Novartis Vaccines And Diagnostics Gmbh & Co Kg | Storage of influenza vaccines without refrigeration |
| GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
| NZ575271A (en) | 2006-09-11 | 2011-09-30 | Novartis Ag | Making influenza virus vaccines without using eggs |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| JP2011506264A (ja) | 2006-12-06 | 2011-03-03 | ノバルティス アーゲー | インフルエンザウイルスの４つの株に由来する抗原を含むワクチン |
| PT2185191E (pt) | 2007-06-27 | 2012-11-27 | Novartis Ag | Vacinas contra a gripe com baixo teor de aditivos |
| GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
| EP2235532B1 (en) | 2007-12-24 | 2013-04-24 | Novartis AG | Assays for adsorbed influenza vaccines |
| US8506966B2 (en) * | 2008-02-22 | 2013-08-13 | Novartis Ag | Adjuvanted influenza vaccines for pediatric use |
| JP5518041B2 (ja) | 2008-03-18 | 2014-06-11 | ノバルティス アーゲー | インフルエンザウイルスワクチン抗原の調製における改良 |
| RU2011107757A (ru) | 2008-08-01 | 2012-09-10 | Гамма Ваксинс Пти Лимитед (Au) | Вакцины против гриппа |
| EP2361304A2 (en) | 2008-11-05 | 2011-08-31 | GlaxoSmithKline Biologicals S.A. | Novel method |
| WO2010089339A1 (en) * | 2009-02-06 | 2010-08-12 | Glaxosmithkline Biologicals S.A. | Purification of virus or viral antigens by density gradient ultracentrifugation |
| EA023662B1 (ru) | 2009-02-10 | 2016-06-30 | Новартис Аг | Вакцины против гриппа со сниженным количеством сквалена |
| JP2012517416A (ja) | 2009-02-10 | 2012-08-02 | ノバルティス アーゲー | 増加した量のｈ３抗原を含むインフルエンザワクチン |
| WO2010092476A1 (en) | 2009-02-10 | 2010-08-19 | Novartis Ag | Influenza vaccine regimens for pandemic-associated strains |
| DE102010018462A1 (de) | 2009-04-27 | 2011-04-07 | Novartis Ag | Impfstoffe zum Schutz gegen Influenza |
| JP5836266B2 (ja) | 2009-05-21 | 2015-12-24 | ノバルティス アーゲー | 非内因性ｐｏｌＩプロモーターを使用した逆遺伝学 |
| WO2011012999A1 (en) | 2009-07-31 | 2011-02-03 | Novartis Ag | Reverse genetics systems |
| CN102695523A (zh) | 2009-09-10 | 2012-09-26 | 诺华有限公司 | 针对呼吸道疾病的组合疫苗 |
| KR20120083480A (ko) | 2009-10-20 | 2012-07-25 | 노파르티스 아게 | 바이러스 구제를 위한 개선된 역유전학 방법 |
| JP6072677B2 (ja) | 2010-05-06 | 2017-02-01 | ノバルティス アーゲー | 微生物の不活化のための有機ペルオキシド化合物 |
| JP5876036B2 (ja) | 2010-05-21 | 2016-03-02 | ノバルティス アーゲー | インフルエンザウイルス再集合方法 |
| PL2575872T3 (pl) | 2010-06-01 | 2021-02-22 | Seqirus UK Limited | Zatężanie antygenów szczepionkowych grypy bez liofilizacji |
| CA2801151A1 (en) | 2010-06-01 | 2011-12-08 | Novartis Ag | Concentration of vaccine antigens with lyophilization |
| WO2011154976A2 (en) | 2010-06-08 | 2011-12-15 | Panacea Biotec Limited | Improved influenza vaccine |
| CA2808965C (en) | 2010-08-20 | 2020-01-07 | Theraject, Inc. | Soluble needle arrays for delivery of influenza vaccines |
| WO2012100302A1 (en) | 2011-01-27 | 2012-08-02 | Gamma Vaccines Pty Limited | Combination vaccines |
| GB201216121D0 (en) | 2012-09-10 | 2012-10-24 | Novartis Ag | Sample quantification by disc centrifugation |
| EP2768528A1 (en) | 2011-10-20 | 2014-08-27 | Novartis AG | Adjuvanted influenza b virus vaccines for pediatric priming |
| WO2013087945A2 (en) | 2012-03-02 | 2013-06-20 | Novartis Ag | Influenza virus reassortment |
| CN104159608A (zh) | 2012-03-06 | 2014-11-19 | 克鲁塞尔荷兰公司 | 针对流感的改善的疫苗接种 |
| WO2013182498A1 (en) | 2012-06-04 | 2013-12-12 | Novartis Ag | Improved safety testing |
| GB201218195D0 (en) | 2012-10-10 | 2012-11-21 | Istituto Zooprofilattico Sperimentale Delle Venezie | Composition |
| US9708585B2 (en) | 2012-12-03 | 2017-07-18 | Seqirus UK Limited | Influenza virus reassortment |
| AU2014204826A1 (en) | 2013-01-10 | 2015-07-09 | Seqirus UK Limited | Influenza virus immunogenic compositions and uses thereof |
| CA2905612A1 (en) | 2013-03-13 | 2014-09-18 | Novartis Ag | Influenza virus reassortment |
| JP2016521282A (ja) | 2013-05-10 | 2016-07-21 | ノバルティス アーゲー | インフルエンザワクチンにおけるナルコレプシーのリスクの回避 |
| DE202013005130U1 (de) | 2013-06-05 | 2013-09-10 | Novartis Ag | Influenza Virus Reassortierung |
| DE202013005100U1 (de) | 2013-06-05 | 2013-08-26 | Novartis Ag | Influenza Virus Reassortierung |
| CN105722976A (zh) | 2013-06-06 | 2016-06-29 | 诺华股份有限公司 | 流感病毒重配 |
| CA2930634C (en) | 2013-11-15 | 2023-05-09 | Novartis Ag | Removal of influenza nuclear protein (np) from influenza virus preparations |
| FR3025107B1 (fr) | 2014-08-29 | 2018-10-05 | Calixar | Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| KR20180035807A (ko) | 2015-06-26 | 2018-04-06 | 세퀴러스 유케이 리미티드 | 항원적으로 매치된 인플루엔자 백신 |
| AU2016290603B2 (en) | 2015-07-07 | 2022-06-02 | Seqirus UK Limited | Influenza potency assays |
| US10626376B2 (en) | 2016-11-14 | 2020-04-21 | St. Jude Children's Research Hospital | Method for isolating and purifying adeno-associated virus particles using salt |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| WO2019086463A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| US20220168413A1 (en) | 2019-02-25 | 2022-06-02 | Seqirus UK Limited | Adjuvanted multivalent influenza vaccines |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| EP4054630A2 (en) | 2019-11-07 | 2022-09-14 | Seqirus UK Limited | Compositions and methods for producing a viral vaccine with reduced particle size |
| EP4061930A1 (en) | 2019-11-18 | 2022-09-28 | Seqirus Pty Ltd | Method for producing reassortant influenza viruses |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| IT202100014747A1 (it) * | 2021-06-07 | 2022-12-07 | Consiglio Nazionale Ricerche | Derivati sterolici come nuovi ligandi del recettore dectina-1 nel trattamento terapeutico di patologie correlate a tale recettore |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1274081A (en) * | 1917-05-10 | 1918-07-30 | Herman A Metz | Hypodermic needle. |
| US1436707A (en) * | 1921-08-10 | 1922-11-28 | American Platinum Works | Adjustable and safety regulating device for hypodermic needles |
| FR1001668A (fr) * | 1946-06-17 | 1952-02-26 | Seringue pour anesthésie tronculaire du maxillaire inférieur | |
| US2559474A (en) * | 1950-03-09 | 1951-07-03 | Sonco Inc | Hypodermic and spinal syringe |
| FR1072399A (fr) * | 1961-01-07 | 1954-09-13 | Injecteur intra-dermique | |
| US3400715A (en) * | 1966-01-04 | 1968-09-10 | Halvard J. Pederson | Attachment for injection apparatus |
| US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
| BE795384A (fr) * | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
| JPS6153226A (ja) * | 1984-08-24 | 1986-03-17 | Chemo Sero Therapeut Res Inst | 単純ヘルペスサブユニツトワクチンの精製方法 |
| CA1283827C (en) * | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
| US6056716A (en) * | 1987-06-08 | 2000-05-02 | D'antonio Consultants International Inc. | Hypodermic fluid dispenser |
| US5569190A (en) * | 1987-06-08 | 1996-10-29 | D'antonio; Nicholas F. | Hypodermic fluid dispenser |
| US5080648A (en) * | 1987-06-08 | 1992-01-14 | Antonio Nicholas F D | Hypodermic fluid dispenser |
| US5195526A (en) * | 1988-03-11 | 1993-03-23 | Michelson Gary K | Spinal marker needle |
| TW279133B (cg-RX-API-DMAC7.html) * | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
| SE9102652D0 (sv) * | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
| US5328483A (en) * | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
| IL101720A (en) * | 1992-04-29 | 1998-09-24 | Mali Tech Ltd | Needle for syringe or the like |
| US5686078A (en) * | 1992-09-14 | 1997-11-11 | Connaught Laboratories, Inc. | Primary and secondary immunization with different physio-chemical forms of antigen |
| CN1124013A (zh) * | 1993-02-19 | 1996-06-05 | 史密丝克莱恩比彻姆公司 | 含3-邻位-脱酰基的单磷酰基脂质a的流感疫苗组合物 |
| CA2156525A1 (en) * | 1993-02-19 | 1994-09-01 | Susan Dillon | Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a |
| US6485729B1 (en) * | 1993-09-13 | 2002-11-26 | Protein Sciences Corporation | Neuraminidase-supplemented compositions |
| US5997501A (en) * | 1993-11-18 | 1999-12-07 | Elan Corporation, Plc | Intradermal drug delivery device |
| GB9620795D0 (en) * | 1996-10-05 | 1996-11-20 | Smithkline Beecham Plc | Vaccines |
| UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| SE9502285D0 (sv) * | 1995-06-22 | 1995-06-22 | Pharmacia Ab | Improvements related to injections |
| US5776107A (en) * | 1996-12-31 | 1998-07-07 | Delab | Injection device |
| IT1298087B1 (it) * | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
| US6494865B1 (en) * | 1999-10-14 | 2002-12-17 | Becton Dickinson And Company | Intradermal delivery device including a needle assembly |
| US6776776B2 (en) * | 1999-10-14 | 2004-08-17 | Becton, Dickinson And Company | Prefillable intradermal delivery device |
| US6843781B2 (en) * | 1999-10-14 | 2005-01-18 | Becton, Dickinson And Company | Intradermal needle |
| US6569143B2 (en) * | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Method of intradermally injecting substances |
| US20020193740A1 (en) * | 1999-10-14 | 2002-12-19 | Alchas Paul G. | Method of intradermally injecting substances |
| US6569123B2 (en) * | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Prefillable intradermal injector |
| EP1361890B1 (en) * | 2001-02-23 | 2011-03-30 | GlaxoSmithKline Biologicals s.a. | Influenza vaccine formulations for intradermal delivery |
| GB0109297D0 (en) * | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
| CA2445120A1 (en) * | 2001-04-27 | 2002-11-07 | Glaxosmithkline Biologicals Sa | Devices for the intradermal administration of influenza vaccines |
| CN1253220C (zh) * | 2001-06-29 | 2006-04-26 | 贝克顿迪肯森公司 | 通过微管在真皮内输入疫苗和基因治疗剂 |
-
2002
- 2002-02-21 WO PCT/EP2002/001843 patent/WO2002067983A1/en not_active Ceased
- 2002-02-21 US US10/469,087 patent/US20040096463A1/en not_active Abandoned
- 2002-02-21 EP EP02722113A patent/EP1361889A1/en not_active Withdrawn
- 2002-02-21 AR ARP020100594A patent/AR032575A1/es not_active Application Discontinuation
- 2002-02-21 CA CA002438960A patent/CA2438960A1/en not_active Abandoned
- 2002-02-21 JP JP2002567348A patent/JP2004536785A/ja not_active Withdrawn
-
2014
- 2014-06-18 US US14/307,729 patent/US20140302090A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004532830A5 (cg-RX-API-DMAC7.html) | ||
| Höglund et al. | ISCOMs and immunostimulation with viral antigens | |
| Zakay-Rones et al. | Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama | |
| Buynak et al. | Vaccine against human hepatitis B | |
| Sun et al. | Protection against lethal challenge by Ebola virus-like particles produced in insect cells | |
| Doyle et al. | Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus | |
| Li et al. | Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice | |
| US4522809A (en) | Process for obtaining lipid envelope virus sub-units, notably antigens for use as vaccines, the products obtained and their applications | |
| US10105440B2 (en) | Synthetic derivatives of MPL and uses thereof | |
| Brühl et al. | Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine | |
| RU2006104113A (ru) | ЭФФЕКТИВНЫЕ ВИРУСОПОДОБНЫЕ ЧАСТИЦЫ (VLPs) ГРИППА | |
| Gorse et al. | Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults | |
| Rimmelzwaan et al. | A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses | |
| Wen et al. | Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge | |
| Vasilev et al. | Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants | |
| Zhou et al. | Adjuvant effects of platycodin D on immune responses to infectious bronchitis vaccine in chickens | |
| Ben Ahmeida et al. | The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus | |
| Hooks et al. | Isolation of a new simian foamy virus from a spider monkey brain culture | |
| KR20170055487A (ko) | 경피 투여용 백신 의약 조성물 | |
| Geissler et al. | Chronic ethanol effects on cellular immune responses to hepatitis B virus envelope protein: an immunologic mechanism for induction of persistent viral infection in alcoholics | |
| JP2019522986A (ja) | 弱毒化突然変異体ジカウイルスをコードするゲノム配列 | |
| JP2022516041A (ja) | Ｂ型肝炎を治療するための薬物製剤、その製造方法及び用途 | |
| Couch et al. | Induction of immunity in man by crystalline adenovirus type 5 capsid antigens | |
| CN108853488A (zh) | 一种含有佐剂组合的ev71疫苗 | |
| JP2023128573A (ja) | 腸管へのウイルス特異的な抗体誘導が可能なノロウイルスワクチン |